FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 2025544-423.51%
Mar 31, 2024-168-86.99%
Mar 31, 2023-1,293-176.60%
Mar 31, 20221,687+411.17%
Mar 31, 2021330-133.28%
Mar 31, 2020-992-588.39%
Mar 31, 2019203-1325.69%
Mar 31, 2018-17-98.68%
Mar 31, 2017-1,255-5506.91%
Mar 31, 201623-94.65%
Mar 31, 2015434-168.91%
Mar 31, 2014-630-172.20%
Mar 31, 2013872-61.84%
Mar 31, 20122,286
AI Chat